CVS Health Co. (NYSE:CVS) Shares Sold by First National Bank Sioux Falls

First National Bank Sioux Falls lessened its position in shares of CVS Health Co. (NYSE:CVS) by 7.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,404 shares of the pharmacy operator’s stock after selling 275 shares during the period. First National Bank Sioux Falls’ holdings in CVS Health were worth $269,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC purchased a new stake in CVS Health during the 4th quarter worth about $508,000. Community Bank & Trust Waco Texas increased its position in CVS Health by 321.0% during the 4th quarter. Community Bank & Trust Waco Texas now owns 15,543 shares of the pharmacy operator’s stock worth $1,227,000 after purchasing an additional 11,851 shares in the last quarter. Stockman Wealth Management Inc. increased its position in CVS Health by 3.0% during the 4th quarter. Stockman Wealth Management Inc. now owns 97,082 shares of the pharmacy operator’s stock worth $7,666,000 after purchasing an additional 2,869 shares in the last quarter. Roble Belko & Company Inc increased its position in CVS Health by 92.6% during the 4th quarter. Roble Belko & Company Inc now owns 5,200 shares of the pharmacy operator’s stock worth $411,000 after purchasing an additional 2,500 shares in the last quarter. Finally, Larson Financial Group LLC increased its position in CVS Health by 874.6% during the 4th quarter. Larson Financial Group LLC now owns 6,452 shares of the pharmacy operator’s stock worth $509,000 after purchasing an additional 5,790 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of several recent analyst reports. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Barclays initiated coverage on CVS Health in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. Piper Sandler lifted their price target on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a report on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $89.44.

CVS Health Stock Down 1.6 %

Shares of CVS traded down $1.13 during trading on Tuesday, reaching $68.50. The company’s stock had a trading volume of 8,441,734 shares, compared to its average volume of 10,757,553. The company has a fifty day moving average of $75.13 and a two-hundred day moving average of $73.77. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25. The company has a market cap of $86.34 billion, a price-to-earnings ratio of 10.74, a P/E/G ratio of 0.92 and a beta of 0.52. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. The business had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business’s revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.99 EPS. On average, sell-side analysts predict that CVS Health Co. will post 8.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.88%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio is presently 41.18%.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.24% of the stock is owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.